Crispr Gene Editing: FDA Could Approve First Genetic Therapy That Might Cure Sickle Cell

The Food and Drug Administration is expected to approve a new gene editing therapy for sickle cell disease, its first green light for a Crispr treatment.

Related Keywords

United Kingdom ,British ,Britain ,Reshma Kewalramani ,Drug Administration On ,Vertex Pharmaceuticals ,Drug Administration ,Boston Based Vertex Pharmaceuticals ,Crispr Therapeutics ,President Reshma Kewalramani ,First Crispr Gene Editing Therapy ,Crispr ,Food And Drug Administration ,Sickle Cell ,Gene Editing ,Vertex ,Exa Cel ,Casgevy ,